The Amount of the Findings of Ultrasound and Computed Tomography Scan in Diagnosis of Non-Alcoholic Fatty Liver

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Radiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

2 Assistant Professor, Department of Radiology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

3 Resident, Department of Radiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

4 Researcher, Babol University of Medical Sciences, Babol, Iran

Abstract

Background: According to the high prevalence of non-alcoholic fatty liver and high rates of ultrasonography candidates for diagnosis of this disease, the aim of this study was to determine the agreement between ultrasound and computed tomography (CT) scan in diagnosis of non-alcoholic fatty liver.Methods: In a cross-sectional study conducted in 2018 at Ali ibn Abitaleb hospital in Rafsanjan, Iran, 100 patients with abdominal CT scan who were suspected to metabolic syndrome were enrolled. All patients underwent CT scan and liver ultrasonography. The degree of agreement between ultrasound and CT scan was investigated in diagnosis of fatty liver.Findings: Fatty liver was diagnosed in 68 patients (68%) in ultrasound and CT scan diagnostic methods; and was not diagnosed in 18 patients (18%) by both diagnostic methods. In contrast, although in 8 patients (8%) fatty liver was found in ultrasonography, they were normal in the CT scan. Six patients (6%) also showed fatty liver in CT scan, while fatty liver was not diagnosed in ultrasound assessment. Overall, the agreement between CT scan and ultrasound findings was 0.63 (P < 0.001).Conclusion: The results of the present study showed that there was a good agreement between ultrasonography and CT scan findings in determining non-alcoholic fatty liver. It seems that ultrasonography is a good diagnostic method for the evaluation of patients with suspected liver transfusion.

Keywords

References

  1. Feher J, Lang I, Nekam K, Muzes G, Deak G. Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis. Acta Med Hung 1988; 45(3-4): 265-76.
  2. Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 2007; 61(7): 877-83.
  3. Merat S, Malekzadeh R, Sohrabi MR, Sotoudeh M, Rakhshani N, Sohrabpour AA, et al. Probucol in the treatment of non-alcoholic steatohepatitis: A double-blind randomized controlled study. J Hepatol 2003; 38(4): 414-8.
  4. Vecera R, Zacharova A, Orolin J, Skottova N, Anzenbacher P. The effect of silymarin on expression of selected ABC transporters in the rat. Vet Med (Praha) 2011; 56(2): 59-62.
  5. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study. J Pediatr 2000; 136(6): 734-8.
  6. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98(5): 960-7.
  7. Ong JP, Younossi ZM. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease. Clin Liver Dis 2005; 9(4): 617-34, vi.
  8. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123(3): 745-50.
  9. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102(12): 2708-15.
  10. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: A review and update. Dig Dis Sci 2010; 55(3): 560-78.
Journal of Isfahan Medical School
Volume 37, Issue 548 - Serial Number 548
September and October 2020
Pages 1180-1184

Files

History

  • Receive Date: 26 February 2019
  • Revise Date: 23 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics